Found: 12
Select item for more details and to access through your institution.
Improving rates of venous thromboembolism prophylaxis in multiple myeloma patients on immunomodulatory drugs through a pharmacy-based system.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 421, doi. 10.1177/1078155221995885
- By:
- Publication type:
- Article
A systematic review of religious beliefs about major end-of-life issues in the five major world religions.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rationale and clinical experience with epidermal growth factor receptor inhibitors in gynecologic malignancies.
- Published in:
- Current Treatment Options in Oncology, 2005, v. 6, n. 2, p. 103, doi. 10.1007/s11864-005-0018-x
- By:
- Publication type:
- Article
A single center experience with romiplostim for the management of chemotherapy‐induced thrombocytopenia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 4, p. E86, doi. 10.1002/ajh.25022
- By:
- Publication type:
- Article
Resveratrol ameliorates TNFα-mediated suppression of erythropoiesis in human CD34<sup>+</sup> cells via modulation of NF-κB signalling.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 1, p. 93, doi. 10.1111/j.1365-2141.2011.08800.x
- By:
- Publication type:
- Article
Single nucleotide polymorphisms in the human TNF gene are associated with anaemia and neutropenia in a cohort of patients with de novo myelodysplastic syndrome.
- Published in:
- 2010
- By:
- Publication type:
- Letter
A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single‐institution experience.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 84, doi. 10.1111/hae.14664
- By:
- Publication type:
- Article
Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e772, doi. 10.1111/hae.14421
- By:
- Publication type:
- Article
The actual and ideal roles of haemophilia treatment centre social workers in the United States and the barriers to ideal roles.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e683, doi. 10.1111/hae.14414
- By:
- Publication type:
- Article
Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 2, p. 221, doi. 10.1111/hae.14222
- By:
- Publication type:
- Article
The "flipped visit": an innovative method to improve medical student self-efficacy through a structured approach in clinic.
- Published in:
- BMC Medical Education, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12909-024-06122-6
- By:
- Publication type:
- Article